<?xml version="1.0" encoding="UTF-8"?>
<p>Chloroquine and its many analogs (such as hydroxychloroquine etc.) have properties of weak acidic amines in unprotonated form as they easily permeate cellular membranes (Chinappi 
 <italic>et al</italic>. 
 <xref rid="bib53" ref-type="bibr">2010</xref>) and after the protonation accumulate in closed cellular compartments with acidic pH (i.e. endosomes or lysosomes) (Vincent 
 <italic>et al</italic>. 
 <xref rid="bib287" ref-type="bibr">2005</xref>). The level of chloroquine in such compartments may be &gt;100 times higher than its concentration in the cell (de Duve 
 <italic>et al</italic>. 
 <xref rid="bib60" ref-type="bibr">1974</xref>). Chloroquine may stay in the isolated intracellular compartments for hundreds of hours (Schrezenmeier and Dorner 
 <xref rid="bib235" ref-type="bibr">2020</xref>). Accumulating in endosomes/lysosomes, chloroquine shifts the pH to alkali (Homewood 
 <italic>et al</italic>. 
 <xref rid="bib108" ref-type="bibr">1972</xref>; Ohkuma and Poole 
 <xref rid="bib198" ref-type="bibr">1978</xref>; Al-Bari 
 <xref rid="bib7" ref-type="bibr">2017</xref>) and inhibits diverse ATPases, including Н
 <sup>+</sup>-ATPase (V-ATPase), which defines the acidification of the environment of endosomes and cisternae of the Golgi apparatus (Chandra 
 <italic>et al</italic>. 
 <xref rid="bib45" ref-type="bibr">1992</xref>; Bhattacharyya and Sen 
 <xref rid="bib21" ref-type="bibr">1999</xref>; Holliday 
 <xref rid="bib105" ref-type="bibr">2017</xref>). It is possible that these many phenomena define the blockade of the release of RNA genome of influenza viruses from the lipoproteins of their envelopes (Shibata 
 <italic>et al</italic>. 
 <xref rid="bib241" ref-type="bibr">1983</xref>), which results in the inhibition of viral replication (Ooi 
 <italic>et al</italic>. 
 <xref rid="bib201" ref-type="bibr">2006</xref>; Di Trani 
 <italic>et al</italic>. 
 <xref rid="bib63" ref-type="bibr">2007</xref>). The ability of chloroquine to inhibit the acidification of endosomes that contain respiratory viruses, and thus to block the release of their RNA genomes and following replication, may partially explain its antiviral activity. Chloroquine also has high antiviral activity against not only influenza A viruses (internalized in the endosomes) but also coronaviruses (Keyaerts 
 <italic>et al</italic>. 
 <xref rid="bib133" ref-type="bibr">2004</xref>; Vincent 
 <italic>et al</italic>. 
 <xref rid="bib287" ref-type="bibr">2005</xref>; Ooi 
 <italic>et al</italic>. 
 <xref rid="bib201" ref-type="bibr">2006</xref>; Yan 
 <italic>et al</italic>. 
 <xref rid="bib305" ref-type="bibr">2013</xref>; de Wilde 
 <italic>et al</italic>. 
 <xref rid="bib62" ref-type="bibr">2014</xref>; Kearney 
 <xref rid="bib129" ref-type="bibr">2020</xref>), which are almost exclusively internalized by membrane fusion, i.e. without the formation of endosomes (Matsuyama 
 <italic>et al</italic>. 
 <xref rid="bib171" ref-type="bibr">2005</xref>).
</p>
